0002088082

IPO filing research

Electra Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · ETRA

ipo amended Nasdaq Global Select Market S-1

Electra Therapeutics, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-08-28. Current deal snapshot: exchange Nasdaq Global Select Market.

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

Common stock · Exchange Nasdaq Global Select Market · Ticker ETRA · Use of proceeds to advance development of ipsoprubart and ELA822, support clinical trials, and fund research and development activities

Electra Therapeutics, Inc. is conducting an IPO with a focus on converting redeemable convertible preferred stock into common stock, implementing a reverse stock split, and detailing financial losses. The filing includes pro forma financial data assuming these conversions and a potential offering. The company remains unprofitable, with significant accumulated deficits and ongoing research and development expenses.

2026-08-28 · 0001193125-26-374259

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2026-08-10 · 0001193125-26-342694

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

2026-06-26 · 0001193125-26-285726

Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 20 using nearest neighbors.

Showing top 8 by similarity.

+6.4%

Median day-1

60%

Above issue

+10.6%

Median week-1

-16.7%

Downside (p10)

Attovia Therapeutics, Inc. ATTO

2026-08-05 $269M Day 1: +28.8% Wk 1: +9.7%

same SICrecent IPO

Scribe Therapeutics, Inc. SCTX

2026-07-24 $129M Day 1: +44.3% Wk 1: +37.2%

same SICrecent IPO

Odyssey Therapeutics, Inc. ODTX

2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%

same SICrecent IPO

Hemab Therapeutics Holdings, Inc. COAG

2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%

same SICrecent IPO

Vogenx, Inc. VOGX

2026-08-12 $81M Day 1: +0.0% Wk 1: +51.9%

same SIC grouprecent IPO

BlossomHill Therapeutics, Inc. BLSM

2026-08-07 $150M Day 1: +0.0% Wk 1: +2.2%

same SIC grouprecent IPO

Latigo Biotherapeutics, Inc. LTGO

2026-08-07 $346M Day 1: +1.4% Wk 1: +11.4%

same SIC grouprecent IPO

Braveheart Bio, Inc. BRVE

2026-08-06 $383M Day 1: +65.6% Wk 1: +45.3%

same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.